Search results for "Hospitalization"

showing 10 items of 463 documents

Do Saharan Dust Days Carry a Risk of Hospitalization From Respiratory Diseases for Citizens of the Canary Islands (Spain)?

2021

Background: Saharan dust meets the Canary Islands at the beginning of its westward path across the North Atlantic, exceeding the European daily levels for PM10; for this reason, their two provincial capital cities, constitute optimal sites where to evaluate the health effects of this natural event. Objectives: To assess the short-term association between Saharan Dust Days (SDDs) and respiratory morbidity in the two capital cities. Methods: We carried out a time-series analysis with daily emergency hospital admissions due to all respiratory system diseases, chronic obstructive pulmonary disease (COPD) and asthma between 2001 and 2005, assessing the independent effect of SDDs, defined accordi…

Pulmonary and Respiratory MedicineSeries temporalesRespiratory diseasesSaharan dustProvincial capitalGeneralized additive modelPulmonary diseaseCalima saharianaMineral dustIngresos hospitalariosPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineAir PollutionEnvironmental healthRespiratory morbiditymedicineHumansAfrican air intrusionsRespiratory systemAsthmaHospital admissionsAir PollutantsCOPDbusiness.industryDustGeneral MedicineIntrusiones de aire africanoRespiration Disordersmedicine.diseaseModelos aditivos generalizadosAsthmaConfidence intervalPartículas en suspensiónHospitalizationEnfermedades respiratorias030228 respiratory systemSpainParticulate MatterTime-seriesbusinessParticulate matter
researchProduct

Retrospective screening for SARS-CoV-2 among influenza-like illness hospitalizations: 2018-2019 and 2019-2020 seasons, Valencia region, Spain

2021

Este artículo se encuentra disponible en la siguiente URL: https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.12899 En este artículo de investigación también participan: Juan Mollar-Maseres, Germán Schwarz-Chavarri, Sandra García-Esteban, Joan Puig-Barberà, Javier Díez-Domingo y F. Xavier López-Labrador. On 9 March 2020, the World Health Organization (WHO) Global Influenza Programme (GIP) asked participant sites on the Global Influenza Hospital Surveillance Network (GIHSN) to contribute to data collection concerning severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We re-analysed 5833 viral RNA archived samples collected prospectively from hospital admissions for influenza-lik…

Pulmonary and Respiratory Medicinemedicine.medical_specialty2019-20 coronavirus outbreakRT‐PCRSARS-CoV-2 (Virus) - Diagnóstico - 2018-2019 - España - Valencia (Comunidad Valenciana)EpidemiologyShort CommunicationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PopulationShort CommunicationscoronavirusData analysis.COVID-19 - Diagnóstico - 2019-2020 - España - Valencia (Comunidad Autónoma)medicine.disease_causeWorld healthCOVID‐19Influenza HumanPandemicmedicineHumansCOVID-19 - Diagnóstico - 2018-2019 - España - Valencia (Comunidad Autónoma)Influenza - Diagnosis - 2019-2020 - Spain - Valencia (Autonomous Community)Viral rnaGripe - Diagnóstico - 2018-2019 - España - Valencia (Comunidad Autónoma)influenza‐like‐illnesseducationRetrospective StudiesCoronaviruseducation.field_of_studyInfluenza-like illnessSARS-CoV-2business.industrySARS-CoV-2 (Virus) - Diagnosis - 2018-2019 - Spain - Valencia (Autonomous Community)COVID-19 (Disease) - Diagnosis - 2019-2020 - Spain - Valencia (Autonomous Community)Public Health Environmental and Occupational HealthCOVID-19virus diseasesCOVID-19 (Disease) - Diagnosis - 2018-2019 - Spain - Valencia (Autonomous Community)Análisis de datos.HospitalizationSARS-CoV-2 (Virus) - Diagnóstico - 2019-2020 - España - Valencia (Comunidad Valenciana)Infectious DiseasesInfluenza - Diagnosis - 2018-2019 - Spain - Valencia (Autonomous Community)SpainGripe - Diagnóstico - 2019-2020 - España - Valencia (Comunidad Autónoma)Emergency medicineSARS-CoV-2 (Virus) - Diagnosis - 2019-2020 - Spain - Valencia (Autonomous Community)Seasonsbusiness
researchProduct

Acute and sustained increase in endothelial biomarkers in COVID-19.

2020

Endothelial injury is related to poor outcomes in respiratory infections yet little is known in relation to COVID-19. Performing a longitudinal analysis (on emergency department admission and post-hospitalisation follow-up), we evaluated endothelial damage via surrogate systemic endothelial biomarkers, that is, proadrenomedullin (proADM) and proendothelin, in patients with COVID-19. Higher proADM and/or proendothelin levels at baseline were associated with the most severe episodes and intensive care unit admission when compared with ward-admitted individuals and outpatients. Elevated levels of proADM or proendothelin at day 1 were associated with in-hospital mortality. High levels maintaine…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industryRespiratory infectionCOVID-19Emergency departmentmedicine.diseaseIntensive care unitlaw.inventionHospitalizationPneumoniaIntensive Care UnitslawDiffusing capacityInternal medicinemedicineCardiologyHumansIn patientHospital MortalityRespiratory systembusinessBiomarkersThorax
researchProduct

Treatment of heart failure with preserved ejection fraction.

2018

Heart failure, in its diverse forms based on the value of the ejection fraction, is associated to high mortality and the frequent need for hospitalization, with a consequent heavy burden on healthcare resources. For an appropriate treatment of heart failure with preserved ejection fraction (HFpEF), there are no specific drugs effective for this condition. Those indicated in HF with reduced EF (HFrEF) are of more benefit in that form of HF, according to the guidelines of the European Society of Cardiology of 2016: ACE-inhibitors, beta-blockers, anti-aldosterones are all indicated with a class of recommendation/level of evidence IA; therapy with loop diuretics is indicated in the case of clin…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyEjection fractionSettore MED/09 - Medicina Internalcsh:Medicineheart failuretherapeutic strategies.Hospitalization rateInternal medicineMedicineAerobic exerciseguidelinesEjection fraction; comorbidity; guidelines; heart failure; therapeutic strategies.Ejection fractionbusiness.industryHigh mortalitylcsh:REvidence-based medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolarecomorbidityHeart failureCardiologyCardiology and Cardiovascular MedicineHeart failure with preserved ejection fractionbusinessguidelineMonaldi archives for chest disease = Archivio Monaldi per le malattie del torace
researchProduct

Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 …

2021

Background The use of Renin-Angiotensin system inhibitors (RASi) in patients with coronavirus disease 2019 (COVID-19) has been questioned because both share a target receptor site. Methods HOPE-COVID-19 (NCT04334291) is an international investigator-initiated registry. Patients are eligible when discharged after an in-hospital stay with COVID-19, dead or alive. Here, we analyze the impact of previous and continued in-hospital treatment with RASi in all-cause mortality and the development of in-stay complications. Results We included 6503 patients, over 18 years, from Spain and Italy with data on their RASi status. Of those, 36.8% were receiving any RASi before admission. RASi patients were …

QA75Malemedicine.medical_specialtyHeart diseaseInfecciones por coronavirusmedicine.medical_treatmentInhibidores enzimáticosPopulationClinical InvestigationsEnfermedad transmisibleAngiotensin-Converting Enzyme InhibitorsSistema renina-angiotensinaComorbidity030204 cardiovascular system & hematologySeverity of Illness Index03 medical and health sciences0302 clinical medicineRisk FactorsOutcome Assessment Health CareSeverity of illnessmedicineHumansRegistries030212 general & internal medicineMedical prescriptioneducationHeart FailureMechanical ventilationeducation.field_of_studySARS-CoV-2business.industryCOVID-19Middle AgedPrognosismedicine.diseaseR1Respiration ArtificialComorbidityHospitalizationItalySpainHeart failureEmergency medicineFemaleObservational studyCardiology and Cardiovascular MedicinebusinessAmerican Heart Journal
researchProduct

Quality of life improved following in-patient substance use disorder treatment

2015

Background Quality of life (QoL) is increasingly recognized as central to the broad construct of recovery in patients with substance use disorders (SUD). However, few longitudinal studies have evaluated changes in QoL after SUD treatment and included patients with SUD that were compulsorily hospitalized. This study aimed to describe QoL among in-patients admitted either voluntarily or compulsorily to hospitalization and to examine patterns and predictors of QoL at admission and at 6 months post treatment. Methods This prospective study followed 202 hospitalized patients with SUD that were admitted voluntarily (N=137) or compulsorily (N=65). A generic QoL questionnaire (QoL-5) was used to as…

Quality of lifeAdultMaleSubstance-Related DisordersResearchHealth StatusPublic Health Environmental and Occupational HealthSubstance use disorder treatmentTreatment outcomesCompulsory hospitalizationMiddle AgedhumanitiesSex FactorsTreatment OutcomeSurveys and QuestionnairesHumansFemaleLongitudinal StudiesProspective StudiesFollow-Up StudiesHealth and Quality of Life Outcomes
researchProduct

Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk

2019

Abstract Aims Studies have shown a non-linear relationship between systolic blood pressure (SBP) and diastolic blood pressure (DBP) and outcomes, with increased risk observed at both low and high blood pressure (BP) levels. We hypothesized that the BP-risk association is different in individuals with and without diabetes at high cardiovascular risk. Methods and results We identified patients with (N = 11 487) or without diabetes (N = 19 450), from 30 937 patients, from 133 centres in 44 countries with a median follow-up of 56 months in the ONTARGET/TRANSCEND studies. Patients had a prior history of stroke, myocardial infarction (MI), peripheral artery disease, or were high-risk diabetics. P…

Ramiprilmedicine.medical_specialtyhypertensionSystoleAngiotensin-Converting Enzyme Inhibitors030204 cardiovascular system & hematologyPeripheral Arterial Disease03 medical and health sciences0302 clinical medicineRamiprilDiastoleRisk FactorsInternal medicineDiabetes mellitusDiabetes MellitusmedicineHumanshigh cardiovascular riskTelmisartan030212 general & internal medicineMyocardial infarctionStrokeRetrospective StudiesHeart Failurediabetesbusiness.industryHazard ratioblood pressureBlood Pressure Determinationmedicine.diseasestrokeHospitalizationmyocardial infarctionBlood pressureCardiovascular DiseasesCase-Control StudiesHeart failureCardiologyDrug Therapy CombinationTelmisartanCardiology and Cardiovascular MedicinebusinessAngiotensin II Type 1 Receptor Blockersmedicine.drugEuropean Heart Journal
researchProduct

Epidemiological characteristics of COVID-19 cases in non-Italian nationals in Sicily: identifying vulnerable groups in the context of the COVID-19 pa…

2022

As in other parts of the world, undocumented migrants in Italy suffer worse health status due to their immigration enforcement situation and other vulnerabilities such as precarious illegal jobs, exploitation and abuse or barriers to higher education, with higher prevalence of chronic noncommunicable diseases. The COVID-19 pandemic, as other pandemics, has not affected everyone equally. The undocumented was one of the most affected groups with regard to hospitalization rates and mortality worldwide. Sicily is one of the gates of entrance to Europe for migrants and asylum seekers from Africa and Asia. Herein, we described the epidemiological characteristics of COVID-19 cases in Sicily to com…

Refugeesaccess to health care; vulnerable populations; migrants; refugee and asylum seeker health care; inequalities in health and health care; health inequalitiesHealth Toxicology and Mutagenesisrefugee and asylum seeker health carePublic Health Environmental and Occupational HealthVulnerable populationsInequalities in health and health careinequalities in health and health careCOVID-19vulnerable populations.MigrantsRefugee and asylum seeker health careHospitalizationhealth inequalitiemigrantItalyAccess to health careaccess to health careHumansPandemicsSicilyHealth inequalities
researchProduct

Antibiotic use and associated factors in a large sample of hospitalised older people

2019

Objectives: The aims of this study were to assess (i) the prevalence of antibiotic use, (ii) factors associated with their use and (iii) the association with in-hospital mortality in a large sample of hospitalised older people in Italy.Methods: Data were obtained from the 2010-2017 REPOSI register held in more than 100 internal medicine and geriatric wards in Italy. Patients aged >= 65 years with at least one antibiotic prescription during their hospitalisation were selected. Multivariable logistic regression models were used to determine factors associated with antibiotic use.Results: A total of 5442 older patients were included in the analysis, of whom 2786 (51.2%) were prescribed anti…

RegistrieMale0301 basic medicineAntibioticsLogistic regression0302 clinical medicineDrug Prescription80 and overPrevalenceImmunology and AllergyLS4_4Hospital MortalityRegistries030212 general & internal medicineMultivariate AnalysiRespiratory Tract InfectionsAged 80 and overAnti-Bacterial AgentsHospitalizationItalyAntibiotic useFemaleHumanMicrobiology (medical)medicine.medical_specialtyLogistic ModelInternal medicine wardmedicine.drug_class030106 microbiologyImmunologySocio-culturaleDrug PrescriptionsMicrobiologyOdds03 medical and health sciencesAntibiotic resistanceAnti-Bacterial AgentmedicineAntibiotic use; Internal medicine ward; Older people; Aged; Aged 80 and over; Anti-Bacterial Agents; Drug Prescriptions; Female; Geriatric Assessment; Hospital Mortality; Hospitalization; Humans; Italy; Logistic Models; Male; Multivariate Analysis; Prevalence; Registries; Respiratory Tract InfectionsHumansMedical prescriptionAntibiotic useGeriatric AssessmentAgedbusiness.industryConfidence intervalLogistic ModelsAntibiotic use Internal medicine ward Older peopleMultivariate AnalysisEmergency medicineOlder peopleOlder peoplebusinessAntibiotic use; Internal medicine ward; Older peopleJournal of Global Antimicrobial Resistance
researchProduct

Comparison of Disease Clusters in Two Elderly Populations Hospitalized in 2008 and 2010

2013

<b><i>Background:</i></b> As chronicity represents one of the major challenges in the healthcare of aging populations, the understanding of how chronic diseases distribute and co-occur in this part of the population is needed. <b><i>Objectives:</i></b> The aims of this study were to evaluate and compare patterns of diseases identified with cluster analysis in two samples of hospitalized elderly. <b><i>Methods:</i></b> Data were obtained from the multicenter ‘Registry Politerapie SIMI (REPOSI)' that included people aged 65 or older hospitalized in internal medicine and geriatric wards in Italy during 2008 and 2010. The s…

RegistrieMaleAgingCirrhosisSettore MED/09 - Medicina InternaTime FactorshispitalizationGerontology; aging populations;atterns of multimorbidity; diseases in the elderly population.Health care80 and overPrevalenceChronic diseases; Cluster analysis; Hospitalized elderlyRegistriesHospitalized elderlyaging populationAged 80 and overeducation.field_of_studySettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheHospitalizationItalyelderly; hispitalization; disease clustersFemaledisease clustershospitalizedHumanmedicine.medical_specialtyTime FactorAnemiaMULTIMORBIDITYPopulationMEDLINEMalignancyelderlyCluster analysisDiabetes mellitusInternal medicinedisease clusters; elderly; hospitalizedmedicinediseases in the elderly population.MultimorbidityHumansatterns of multimorbidityeducationAgedChronic diseases; Cluster analysis; Hospitalized elderly; Aged; Aged; 80 and over; Chronic Disease; Female; Hospitalization; Humans; Italy; Male; Prevalence; Registries; Time Factors; Cluster Analysis; Aging; Geriatrics and GerontologyCluster Analysibusiness.industrymedicine.diseaseChronic diseasesChronic DiseasePhysical therapydisease clusterGeriatrics and GerontologybusinessGerontologyChronic diseases; Cluster analysis; Hospitalized elderly; Aged; Aged 80 and over; Chronic Disease; Female; Hospitalization; Humans; Italy; Male; Prevalence; Registries; Time Factors; Cluster Analysis; Aging; Geriatrics and Gerontology
researchProduct